Impact of combining Lenvatinib with Transarterial chemoembolization for unresectable hepatocellular carcinoma.

Long, Jianwu; Liu, Longfei; Yang, Xuefeng; Lu, Xianzhou; Qin, Lei.

Afiliação

Long J; Jianwu Long, Department of General Surgery, The First Affiliated Hospital of Soochow University, Soochow, Jiangsu province, P.R. China.
Liu L; Longfei Liu, Department of Hepatobiliary Surgery, The Affiliated Nanhua Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan province, P.R. China.
Yang X; Xuefeng Yang, Department of Hepatobiliary Surgery, The Affiliated Nanhua Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan province, P.R. China.
Lu X; Xianzhou Lu Department of General Surgery, Hengyang County People's Hospital, Hengyang, Hunan province, P.R. China.
Qin L; Lei Qin, Department of General Surgery, The First Affiliated Hospital of Soochow University, Soochow, Jiangsu province, P.R. China.

Pak J Med Sci ; 39(6): 1847-1852, 2023.

Article em En | MEDLINE | ID: mdl-37936761